Anticancer Treatments and Cardiotoxicity
Anticancer Treatments and Cardiotoxicity

Author: Patrizio Lancellotti

Publisher: Academic Press

Published: 2016-11-11

Total Pages: 483

ISBN-13: 0128026472

DOWNLOAD EBOOK

Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality in cancer survivors and is one of the most common post-treatment issues among survivors of adult cancer. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is essential in the fight to decrease cardiotoxic mortality. This illustrated reference describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment. In addition, new guidelines on imaging for the screening and monitoring of these patients are also presented. Anticancer Treatments and Cardiotoxicity is an essential reference for those involved in the research and treatment of cardiovascular toxicity. - Provides algorithms essential for the use of imaging, and biomarkers for the screening and monitoring of patients - Written by world-leading experts in the field of cardiotoxicity - Includes high-quality images, case studies, and test questions - Describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment

Anticancer Treatments and Cardiotoxicity
Anticancer Treatments and Cardiotoxicity

Author: Patrizio Lancellotti

Publisher: Academic Press

Published: 2016-12-06

Total Pages: 0

ISBN-13: 9780128025093

DOWNLOAD EBOOK

Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality in cancer survivors and is one of the most common post-treatment issues among survivors of adult cancer. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is essential in the fight to decrease cardiotoxic mortality. This illustrated reference describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment. In addition, new guidelines on imaging for the screening and monitoring of these patients are also presented. Anticancer Treatments and Cardiotoxicity is an essential reference for those involved in the research and treatment of cardiovascular toxicity.

Cardiotoxicity
Cardiotoxicity

Author: Wenyong Tan

Publisher: BoD – Books on Demand

Published: 2018-11-14

Total Pages: 164

ISBN-13: 1789842379

DOWNLOAD EBOOK

Cardiotoxicity may be caused by radiotherapy and/or anticancer agents for many malignancies, adverse effects of some drugs in the context of medical intervention or heavy metal intake, especially during the anticancer therapy. This book intends to bring forward the recent development in toxicities from cancer treatment. It updates the possible mechanisms of cardiotoxicities of some anticancer agents and the suggested prevention and treatment strategies. This book contains many valuable contributions from the researchers in oncology and cardiology as well as the clinicians who are experts in this field.

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology
Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology

Author: Imteyaz Qamar

Publisher: Academic Press

Published: 2022-05-26

Total Pages: 278

ISBN-13: 0323904629

DOWNLOAD EBOOK

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-Oncology: From Basic Research to Advanced Study analyzes the emerging the field of cardio-oncology, reviewing recent advancements in the field, discussing how to monitor and treat cancer survivors for cardiotoxicity, and identifying potential cardiac side effects in novel cancer therapies. By adopting a translational approach, the book first comprehensively covers the basic science, mechanisms and concepts, which is followed by advanced state-of-art of cardio-oncology. Other sections cover tyrosine kinase inhibitors, Anthracyclines, and biomarkers in cardiotoxicity induced by chemotherapeutic drugs, noninvasive cardiovascular imaging techniques, radiotherapy induced cardiovascular, and more. Anti-cancer treatment is associated with serious cardiovascular adverse events, including arterial and pulmonary hypertension, supraventricular and ventricular arrhythmias, systolic and diastolic cardiac dysfunction and coronary artery disease. Progress in cancer therapy over the past decades improved long-term survival but increased cancer therapy-related cardiotoxicity. Both traditional chemotherapeutic agents and newer therapies have demonstrated profound cardiovascular toxicities. It is important to understand the mechanisms of these toxicities to establish strategies for the prevention and management of complications—arrhythmias, heart failure, and even death. - Adopts a translational approach and comprehensively covers the basic science, mechanisms and concepts of cardio-oncology - Outlines the current knowledge of biomarkers in cancer therapy-related cardiotoxicity - Provides an understanding of the mechanisms of cardiovascular toxicity of various therapies that may lead to the identification of novel targets to reduce vascular complications

Endocrine and Metabolic Late Effects in Cancer Survivors
Endocrine and Metabolic Late Effects in Cancer Survivors

Author: Francesco Felicetti (Oncologist)

Publisher: Karger Medical and Scientific Publishers

Published: 2021-11

Total Pages: 169

ISBN-13: 3318067911

DOWNLOAD EBOOK

This book analyzes in detail all aspects related to endocrine and metabolic late effects observed in patients treated for cancer, both in childhood and adulthood. The chapters focusing on the possible pathogenic mechanisms of late effects (i.e., premature aging and chronic inflammation) and on bone health in cancer survivors are particularly interesting and innovative. The volume also deals with hypothalamic-pituitary, thyroid and gonadal disorders, including infertility and how to prevent it. Finally, the relationship between metabolic alterations and cardiovascular diseases in cancer survivors is addressed. Thanks to advances in cancer treatment and supportive care, the five-year survival rate of cancer patients is constantly increasing. However, this undisputable success of medicine has a flip side: the late adverse effects of anticancer therapies. Pediatric oncologists were the first to cope with late complications of treatments, but today also adult oncologists and onco-hematologists recognize the relevance of this issue. Even though late effects observed in cancer survivors can affect any organ or system, endocrine and metabolic dysfunctions are the most frequently reported. Endocrine complications rarely influence life expectancy of cancer survivors, but they can significantly impact morbidity and quality of life. Among endocrine adverse effects, severe hypothalamic damage may be considered the most harmful in survivors, leading to morbid obesity, propensity to metabolic syndrome and cardiovascular disease. This book aims to disseminate the knowledge about endocrine and metabolic adverse effects of cancer therapies and about survivorship care. Since the number of cancer survivors is steadily growing in the general population, this publication is intended not only for endocrinologists but also for oncologists, onco-hematologists, internists, pediatric specialists in those areas and general practitioners, with the aim to better counsel and monitor cancer survivors.

Late Treatment Effects and Cancer Survivor Care in the Young
Late Treatment Effects and Cancer Survivor Care in the Young

Author: Jörn D. Beck

Publisher: Springer Nature

Published: 2020-11-05

Total Pages: 419

ISBN-13: 3030491404

DOWNLOAD EBOOK

This comprehensive guide describes the aftercare that is appropriate in young cancer patients and discusses in detail the risk and detection of treatment sequelae. It explains the impacts on body and mind of both the disease itself and the different risk-adapted cancer treatments currently in use. Clear guidance is provided on diagnosis and management of the principal treatment-related toxicities in different organs and organ systems and for a wide variety of tumor types. In addition, the role of genetic polymorphisms in the development of adverse therapy-related outcomes is explored, and advice offered on genetic counselling. As the number of long-term survivors of childhood cancer and of cancer in young adults continues to grow, so issues surrounding potential sequelae, second malignancies, and quality of life are becoming ever more important. All practitioners involved in the care of young cancer patients will find this book to be a helpful source of up-to-date information and assistance.

Oncologic Critical Care
Oncologic Critical Care

Author: Joseph L. Nates

Publisher: Springer

Published: 2019-10-30

Total Pages: 2099

ISBN-13: 9783319745879

DOWNLOAD EBOOK

This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients.

MD Anderson Practices in Onco-Cardiology
MD Anderson Practices in Onco-Cardiology

Author: Edward T. H. Yeh.

Publisher:

Published: 2016-03-08

Total Pages:

ISBN-13: 9781944785949

DOWNLOAD EBOOK

The Department of Cardiology at The University of Texas MD Anderson Cancer Center was established on September, 1, 2000. In the past 15 years, we have evaluated and treated more than 10,000 cancer patients with cancer ther¬apy-related cardiovascular complications. Three years ago, we initiated the MD Anderson Practice (MAP) project to distillate our practice patterns into al¬gorithms to be shared with the onco-cardiology community. Because cancer is often an exclusion criterion for cardiology studies, purely evidence-based man¬agement of cancer therapy-related cardiovascular complications is not possible. With this vacuum of knowledge, various "guidelines" have proliferated that are either misleading or difficult to practice. In this manual, we present 16 MAPs that have been extensively reviewed by the cardiologists at MD Anderson. These MAPs should be considered our best practices rather than "guidelines." These MAPs will be updated frequently to reflect advances in the field. This manual con¬sists of MAPs, figures, and tables. We hope you will find these materials useful to your practice and provide us with feedback to improve these MAPs.

Advanced Imaging Modalities
Advanced Imaging Modalities

Author: Steffen Rickes

Publisher: S. Karger AG (Switzerland)

Published: 2004-01-01

Total Pages: 94

ISBN-13: 9783805577779

DOWNLOAD EBOOK

Imaging technologies are the cornerstone in the diagnosis and staging of benign and malignant lesions in the liver and pancreas. Although the methods are partly competing, they often need to be used in a complementary way in order to obtain optimal results for decision making. The introduction of new and refined non-invasive imaging technologies has lately led to a major progress in the diagnostic approach to diseases of the digestive system. For example, this is the case with echo-enhanced sonography: This technique is based on the property of microbubbles to resonate and emit harmonic waves in an ultrasound field. The initial method, defined as 'second harmonic imaging', was limited by the incapacity to separate the signals obtained from the bubbles and the tissue texture. This procedure has been replaced by the pulse inversion imaging technique which now gives a much better picture quality, allowing to depict the vascularization pattern of distinct lesions in the liver and pancreas. Similarly, the performance of other key imaging modalities such as CT-scan, magnetic resonance imaging, Doppler sonography and endosonography has been improved. Clinicians seeking current information on modern imaging modalities for diagnosis, differentiation and staging of gastrointestinal diseases will find this publication very useful.